October 20, 2026
Breaking
Business

Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis

admin1 min read

Novo released new evidence that its experimental CagriSema injection can improve upon the weight loss with its blockbuster GLP-1 obesity injection, Wegovy.

The post Novo's next-generation obesity drug shows 25% weight loss in women in late-stage analysis appeared first on Business News.

Leave a Comment

Your email address will not be published. Required fields are marked *